Artwork

İçerik Karger Publishers tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Karger Publishers veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.
Player FM - Podcast Uygulaması
Player FM uygulamasıyla çevrimdışı Player FM !

S1 E2 – Part 1: Changing Landscape in Managing Breast Cancer Patients with Dr Dawood

18:52
 
Paylaş
 

Manage episode 407348232 series 3559566
İçerik Karger Publishers tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Karger Publishers veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

The second episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, to discuss the changing landscape in managing breast cancer patients. To accompany this series on breast cancer, Karger have produced a summary sheet showcasing the breast cancer highlights from this year’s ASCO 2022 meeting. The sheet is available to download for free from Karger’s platform - https://www.karger.com/WebMaterial/ShowFile/1449609

For more podcast episodes from Karger please visit karger.com/podcasts.

This episode has been made possible by the contribution from Mylan Pharmaceuticals Private Limited, A Viatris Company. Viatris did not have any influence on the content and all items were subject to independent editorial review. These contents should not be construed to be medical, or consulting advice. The viewers assume all risk for use of the information and the content provided in the podcast episode. In no event shall Mylan Pharmaceuticals Private Limited or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages of any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has been informed of the possibility in advance, resulting from or in connection with the creation or use of or reliance in the podcast episode.

  continue reading

17 bölüm

Artwork
iconPaylaş
 
Manage episode 407348232 series 3559566
İçerik Karger Publishers tarafından sağlanmıştır. Bölümler, grafikler ve podcast açıklamaları dahil tüm podcast içeriği doğrudan Karger Publishers veya podcast platform ortağı tarafından yüklenir ve sağlanır. Birinin telif hakkıyla korunan çalışmanızı izniniz olmadan kullandığını düşünüyorsanız burada https://tr.player.fm/legal özetlenen süreci takip edebilirsiniz.

The second episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, to discuss the changing landscape in managing breast cancer patients. To accompany this series on breast cancer, Karger have produced a summary sheet showcasing the breast cancer highlights from this year’s ASCO 2022 meeting. The sheet is available to download for free from Karger’s platform - https://www.karger.com/WebMaterial/ShowFile/1449609

For more podcast episodes from Karger please visit karger.com/podcasts.

This episode has been made possible by the contribution from Mylan Pharmaceuticals Private Limited, A Viatris Company. Viatris did not have any influence on the content and all items were subject to independent editorial review. These contents should not be construed to be medical, or consulting advice. The viewers assume all risk for use of the information and the content provided in the podcast episode. In no event shall Mylan Pharmaceuticals Private Limited or any of its affiliates, directors, employees, officers, consultants and service providers be liable for, directly or indirectly, any damages of any kind or nature, including without limitation, direct, indirect, incidental, consequential, or any claims or losses, whether foreseeable or not; or whether the user has been informed of the possibility in advance, resulting from or in connection with the creation or use of or reliance in the podcast episode.

  continue reading

17 bölüm

Tüm bölümler

×
 
Loading …

Player FM'e Hoş Geldiniz!

Player FM şu anda sizin için internetteki yüksek kalitedeki podcast'leri arıyor. En iyi podcast uygulaması ve Android, iPhone ve internet üzerinde çalışıyor. Aboneliklerinizi cihazlar arasında eş zamanlamak için üye olun.

 

Hızlı referans rehberi